EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Femoral–Femoral Artery Artificial Vascular Bypass: A Promising Therapy for Infectious Arteritis After Kidney Transplantation

Jiangwei Zhang, Minyue Zhang, Enbo Li, Xiaoming Ding iD

Journal of Transplantation · 2026-01 · 2026 (1)

DOI: 10.1155/joot/9632239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Transplantation, online erschienen am 03.06.2026. Verfasst von Jiangwei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Transplantation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China, xjtu.edu.cn. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Infectious arteritis involving the iliac arteries is a rare but severe complication after kidney transplantation, frequently leading to graft loss and mortality. Direct repair within infected fields is often unsuccessful. We report outcomes of femoral–femoral artery artificial vascular bypass (Fem–Fem bypass) as a strategy to exclude infected arterial segments and preserve limb perfusion in five such cases.

Method

Retrospective analysis of four kidney transplant recipients who developed infectious arteritis (external iliac artery) with rupture or aneurysm between January 2015 and January 2023. All underwent resection of the infected arterial segment with proximal/distal ligation and extra‐anatomic Fem–Fem bypass using a synthetic graft.

Results

Among the four patients, two were infected with carbapenem‐resistant Pseudomonas aeruginosa (CRPA), one with carbapenem‐resistant Enterobacteriaceae (CRE), and one with mucormycosis. All underwent Fem‐Fem bypass following resection of the infected arterial segment. One patient with CRPA infection died 5 months postoperatively due to septicemia and multiorgan failure. The remaining three patients survived with functional grafts and patent bypasses at follow‐up, without recurrence of infection or vascular complications.

Conclusions

Fem–Fem bypass effectively controls hemorrhage or aneurysm expansion and maintains limb perfusion by excluding the infected iliac arterial segment in kidney transplant recipients with infectious arteritis. It represents a viable salvage option when endovascular repair fails or is contraindicated. Long‐term success depends on effective infection control, appropriate antimicrobial therapy, and patient‐specific factors. Mortality remains significant in cases with systemic sepsis or highly resistant pathogens.

Schlagwörter

Stichwörter der Autor:innen

carbapenem-resistant Enterobacteriaceae (CRE)carbapenem-resistant Pseudomonas aeruginosa (CRPA)femoral-to-femoral artery artificial vascular bypass (Fem-Fem bypass)infectious arteritiskidney transplantationmucormycosis

Autor:innen und Institutionen

  • Department of Kidney Transplantation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China, xjtu.edu.cn.

ORCID-Profile: Xiaoming Ding

Zitieren

APA

Zhang, J., Zhang, M., Li, E., & Ding, X. (2026). Femoral–Femoral Artery Artificial Vascular Bypass: A Promising Therapy for Infectious Arteritis After Kidney Transplantation. Journal of Transplantation, 2026(1). https://doi.org/10.1155/joot/9632239

Vancouver

Zhang J, Zhang M, Li E, Ding X. Femoral–Femoral Artery Artificial Vascular Bypass: A Promising Therapy for Infectious Arteritis After Kidney Transplantation. Journal of Transplantation. 2026;2026(1). doi:10.1155/joot/9632239

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiangwei and Zhang, Minyue and Li, Enbo and Ding, Xiaoming},
  title = {Femoral–Femoral Artery Artificial Vascular Bypass: A Promising Therapy for Infectious Arteritis After Kidney Transplantation},
  journal = {Journal of Transplantation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/joot/9632239}
}
Kostenlos starten →